CHEST Impact Factor 2022ChestnetThe ChestCHEST Journal indexingPulmonary articlesChest open accessCHEST journal 2022Chest Radiology JournalCHEST Impact Factor 2022
po文清單文章推薦指數： 80 %
關於「CHEST Impact Factor 2022」標籤，搜尋引擎有相關的訊息討論：
延伸文章資訊
- 1Benralizumab, an anti-interleukin 5 receptor α monoclonal ...
Interpretation: Benralizumab at 20 mg and 100 mg doses seemed to reduce asthma exacerbations in a...
- 2Severe Eosinophilic Asthma Treatment | FASENRA ...
Do not use FASENRA if you are allergic to benralizumab or any of the ingredients in FASENRA. Do n...
- 3PK/PD and Long Term Safety Study of Benralizumab in ...
To evaluate the pharmacokinetics (PK) of Benralizumab administered subcutaneously (SC) in childre...
- 4Study to Evaluate Efficacy and Safety of Benralizumab in ...
This is a study designed to evaluate efficacy and safety of Benralizumab in reducing the Oral Cor...
- 5Benralizumab, an anti-interleukin-5 receptor α monoclonal ...
Background: Benralizumab is a humanised, afucosylated, anti-interleukin-5 receptor α monoclonal a...
